BE636865A - - Google Patents

Info

Publication number
BE636865A
BE636865A BE636865DA BE636865A BE 636865 A BE636865 A BE 636865A BE 636865D A BE636865D A BE 636865DA BE 636865 A BE636865 A BE 636865A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE636865A publication Critical patent/BE636865A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/62—Alcohols or phenols
    • C08G59/64—Amino alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F27—FURNACES; KILNS; OVENS; RETORTS
    • F27B—FURNACES, KILNS, OVENS, OR RETORTS IN GENERAL; OPEN SINTERING OR LIKE APPARATUS
    • F27B14/00—Crucible or pot furnaces
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
BE636865D 1962-08-31 BE636865A (US08034370-20111011-C00001.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1040462 1962-08-31

Publications (1)

Publication Number Publication Date
BE636865A true BE636865A (US08034370-20111011-C00001.png)

Family

ID=4362857

Family Applications (1)

Application Number Title Priority Date Filing Date
BE636865D BE636865A (US08034370-20111011-C00001.png) 1962-08-31

Country Status (9)

Country Link
US (1) US3432592A (US08034370-20111011-C00001.png)
AT (1) AT249269B (US08034370-20111011-C00001.png)
BE (1) BE636865A (US08034370-20111011-C00001.png)
DE (1) DE1229248B (US08034370-20111011-C00001.png)
DK (1) DK104194C (US08034370-20111011-C00001.png)
ES (1) ES291239A1 (US08034370-20111011-C00001.png)
GB (1) GB996819A (US08034370-20111011-C00001.png)
NL (1) NL297357A (US08034370-20111011-C00001.png)
SE (1) SE317156B (US08034370-20111011-C00001.png)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511914A (en) * 1967-01-31 1970-05-12 Schering Corp Throat lozenge vehicle
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
DE2612889B1 (de) * 1976-03-26 1977-09-01 Basf Ag UEberzugsmittel fuer Arzneiformlinge
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
WO1984004674A1 (en) * 1983-05-31 1984-12-06 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
US4882167A (en) * 1983-05-31 1989-11-21 Jang Choong Gook Dry direct compression compositions for controlled release dosage forms
US4548990A (en) * 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4624849A (en) * 1984-11-02 1986-11-25 The Procter & Gamble Company Antimicrobial lozenges
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
US4961932A (en) * 1987-10-26 1990-10-09 Alza Corporation Plurality of tiny pills in liquid dosage form
US5030454A (en) * 1987-10-26 1991-07-09 Alza Corporation Method for delivering drug in tiny pills in liquid carrier
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
DE4138513A1 (de) * 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
ES2096103T3 (es) * 1992-01-13 1997-03-01 Pfizer Preparacion de comprimidos de resistencia incrementada.
DE4226753A1 (de) * 1992-08-13 1994-02-17 Basf Ag Wirkstoffe enthaltende Zubereitungen in Form fester Teilchen
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) * 1995-06-02 2006-12-14 Allergan, Inc. Compositions and methods for treating glaucoma
DE19629040A1 (de) * 1996-07-19 1998-01-22 Basf Ag Pflanzenextrakthaltige Arzneiformen
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2250504T3 (es) 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
BR0213591A (pt) * 2001-09-28 2004-08-31 Mcneil Ppc Inc Composição comestìvel e forma de dosagem compreendendo uma parte externa comestìvel
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
ES2540247T3 (es) * 2002-03-11 2015-07-09 Novartis Ag Dispositivo implantable de administración de medicamentos para el ojo
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050100608A1 (en) * 2003-02-21 2005-05-12 Watson Pharmaceuticals, Inc. Testosterone oral dosage formulations and associated methods
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
US8802128B2 (en) * 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US20070298073A1 (en) * 2006-06-23 2007-12-27 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT214573B (US08034370-20111011-C00001.png) * 1959-12-17 1961-04-10 Abbott Laboratories
US2072302A (en) * 1931-03-10 1937-03-02 Chemische Forschungs Gmbh Polymerized vinyl alcohol articles and processes of making same
US2146295A (en) * 1931-03-10 1939-02-07 Chemische Forschungs Gmbh Polymerized vinyl alcohol articles and process of making same
DE631201C (de) * 1932-08-07 1936-06-16 Chemische Forschungs Gmbh Traegerstoff fuer Arzneimittel
FR732895A (fr) * 1932-10-18 1932-09-25 Consortium Elektrochem Ind Objets filés en alcool polyvinylique
NL44885C (US08034370-20111011-C00001.png) * 1935-11-09
US2538127A (en) * 1948-02-26 1951-01-16 Searle & Co Medicated suppositories and bases therefor
US2584166A (en) * 1948-05-25 1952-02-05 Ayerst Mckenna & Harrison Suppository
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
BE575343A (US08034370-20111011-C00001.png) * 1955-09-09
US2854378A (en) * 1955-12-08 1958-09-30 Bristol Lab Inc Tetracycline suppository
NL107447C (US08034370-20111011-C00001.png) * 1957-08-28
US2975099A (en) * 1958-06-25 1961-03-14 Upjohn Co Polyethylene glycol suppository bases
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3080346A (en) * 1958-11-15 1963-03-05 Bayer Ag Sustained-release pharmaceutical preparations
US3087860A (en) * 1958-12-19 1963-04-30 Abbott Lab Method of prolonging release of drug from a precompressed solid carrier
US2987484A (en) * 1959-05-29 1961-06-06 Procter & Gamble Closed die molding a detergent bar
US3034177A (en) * 1959-07-30 1962-05-15 Procter & Gamble Molding apparatus and method
NL265428A (US08034370-20111011-C00001.png) * 1960-06-06

Also Published As

Publication number Publication date
ES291239A1 (es) 1964-02-16
DE1229248B (de) 1966-11-24
US3432592A (en) 1969-03-11
GB996819A (en) 1965-06-30
SE317156B (US08034370-20111011-C00001.png) 1969-11-10
NL297357A (US08034370-20111011-C00001.png)
AT249269B (de) 1966-09-12
DK104194C (da) 1966-04-18

Similar Documents

Publication Publication Date Title
BE616548R (US08034370-20111011-C00001.png)
BE559145A (US08034370-20111011-C00001.png)
BE613108A (US08034370-20111011-C00001.png)
BE634382A (US08034370-20111011-C00001.png)
BE614986A (US08034370-20111011-C00001.png)
BE615244A (US08034370-20111011-C00001.png)
BE614757A (US08034370-20111011-C00001.png)
BE615294A (US08034370-20111011-C00001.png)
NL297357A (US08034370-20111011-C00001.png)
AU269855A (US08034370-20111011-C00001.png)
AU480751A (US08034370-20111011-C00001.png)
BE634311A (US08034370-20111011-C00001.png)
BE380301A (US08034370-20111011-C00001.png)
BE634301A (US08034370-20111011-C00001.png)
BE489310A (US08034370-20111011-C00001.png)
BE633654A (US08034370-20111011-C00001.png)
BE615316A (US08034370-20111011-C00001.png)
BE538252A (US08034370-20111011-C00001.png)
BE538831A (US08034370-20111011-C00001.png)
BE615521A (US08034370-20111011-C00001.png)
BE541929A (US08034370-20111011-C00001.png)
BE553896A (US08034370-20111011-C00001.png)
BE586180A (US08034370-20111011-C00001.png)
BE592434A (US08034370-20111011-C00001.png)
BE633165A (US08034370-20111011-C00001.png)